首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1352140

全球心内超音波心动图设备市场 - 2023-2030

Global Intracardiac Echocardiography Devices Market - 2023-2030

出版日期: 2023年09月27日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

心内超音波心动图 (ICE) 利用声波以与经胸超音波心动图或「标准」超音波心动图完全相同的方式建构心臟影像。然而，透过心内超音波心动图检查，将带有超音波感测器的小导管插入心臟，可以获得完美的心臟影像，以帮助诊断和治疗特殊的心臟疾病。

心内超音波心动图(ICE) 是一种独特的导管成像技术，通常用于辅助房间隔缺损(ASD)、卵圆孔未闭(PFO) 和室间隔缺损(VSD) 的闭合技术，这些干预措施专门作为心臟直视手术进行几年前。心内超音波心动图广泛用于指导结构性心臟病和心律不整的经导管干预，以简化手术成功并最大限度地减少复杂性。

心血管疾病病例的增加、合併、收购、产品推出等市场发展、意识的提高等因素预计将推动预测期内全球心内超音波心动图设备市场的成长。此外，不断增长的研究活动、技术进步以及心内超音波心动图设备的资金投入预计也将促进预测期内全球市场的成长。

动力学

心血管疾病盛行率增加

心血管疾病病例的增加是预计在预测期内推动全球市场成长的主要因素之一。例如，根据欧洲心血管协会的数据，在 ESC 相关国家，每年有超过 1,260 万人患有 CVD。心血管疾病是 ESC 成员国男性死亡的首要原因 (39%)，而 ESC 伙伴国家每年有 220 万名女性因心血管疾病死亡，欧盟约有 40% 的女性死于心血管疾病。

此外，根据英国心臟基金会2023 年4 月发布的英国情况说明书，英国约有760 万人患有心臟和循环系统疾病，人口老化和人口增长以及心臟和循环系统疾病存活率的提高可能会见证这些数字进一步增长。英国约有400万男性和超过360万名女性患有心臟和循环系统疾病，据估计，英国超过一半的居民在其一生中会遇到心臟或循环系统疾病。

此外，英国患有心臟和循环系统疾病的人数大约是癌症和阿兹海默症病例数量的两倍。在英国，心臟和循环系统疾病约占所有死亡人数的 25%；每年有超过 16 万人死亡，或每天 460 人死亡，每三分钟就有 1 人死亡，英国每年约有 48,000 名 75 岁以下的人死于心臟和循环系统疾病。

产品核准数量不断增加

预计不同监管机构批准的产品数量不断增加也将有助于预测期内全球心内超音波心动图设备市场的成长。例如，2022 年4 月，Franklin Mountain Medical 获得了FDA 对其专利UltraNav 房间隔导管系统的授权，这是一种双腔导管，允许通过一个双腔设备并排、同时输送ICE 和房间隔针或导管，用于治疗透过房间隔穿刺将心血管导管和导丝稳定地进入和输送至心室。

同样，2021 年6 月，西门子Healthineers 的AcuNav Volume ICE（心内超音波心动图）导管获得了CE 标誌，这是一种支持治疗的成像指南，可在结构性心臟和电生理学操作中提供心臟解剖结构的即时、广角可视化。 AcuNav Volume ICE 是市场上最重要的 Volume ICE 导管，其设计基于 ICE 20 年的创新记录。

心内超音波心动图设备成本高

心内超音波心动图设备和导管的高成本预计将阻碍预测期内全球心内超音波心动图设备市场的成长。例如，根据购买的导管数量，相控阵 ICE 导管的成本从 2,000 美元到 2,500 美元不等。同样，心臟 3D 测绘系统的平均清单成本从 25 万美元到 80 万美元不等。

同样，Boston Scientific 的 iLAB 心内成像超音波成像系统售价约为 131,400 美元。此外，心内超音波心动图导管系统的平均成本（2000-2500美元）是心内超音波心动图普遍使用的重要障碍，减缓了预测期内全球心臟超音波设备的市场需求。

心臟科医师劳动力短缺

预计心臟科专家的劳动力缺口将阻碍预测期内全球心内超音波心动图设备市场的成长。例如，根据美国心臟病学会基金会的说法，由于没有足够的临床医生来满足不断增长的患者群体的需求，心臟病学专业领域正处于令人担忧的边缘。同样，根据高收入国家欧洲心臟病学会的数据，每百万居民中心臟科医生的中位数为 99.0 人，而中等收入国家为 61.1 人。

此外，根据印度心臟学会 (CSI) 的数据，在该国 13 亿人口中，只有 5500 名心臟病专家，而该国 30, 000 名居民中只有一名心臟病专家。同样，根据美国医学院协会 (AAMC) 最近的一项调查，到 2034 年，预计美国将缺乏 37,000 至 124,000 名医务人员。其中包括 17,000 至 48,000 名初级保健医生和 3,000 至 13,000 名专家（其中包括心臟病专家）的缺口。

Overview

Intracardiac Echocardiography (ICE) utilizes sound waves to construct pictures of the heart in the exact manner that a transthoracic or "standard" echocardiogram accomplishes. Nevertheless, with intracardiac echocardiography, a small catheter with an ultrasound sensor is inserted into the heart where perfect pictures of the heart can be acquired to aid in diatinct cardiological condition diagnosis and management.

The Intracardiac Echocardiography (ICE) is a unique catheter imaging technology usually utilized to aid closure techniques for atrial septal defects (ASD), patent foramen ovale (PFO), and ventricular septal defects (VSD), interventions exclusively conducted as open-heart surgical operations a few years ago. Intracardiac echocardiography is vastly employed to direct transcatheter interventions for structural cardiac disorder and arrhythmia, to streamline procedural success and minimize intricacies.

The growing cases of cardiovascular disorders, market developments including mergers, acquisitions, products introductions among others, growing awareness among other factors are expected to boost the global intracardiac echocardiography devices market growth in the forecast period. Further, the growing research activities, technological advancements and with fundings in intracardiac echocardiography devices are also expected to contribute to the global market growth in the forecast period.

Dynamics

Increasing Prevalence of Cardiovascular Disorders

The growing cases of cardiovascular condition is among the primary factor that is expected to boost the global market growth in the forecast period. For instance, according to the European Cardiovascular Society, over 12.6 million individuals suffer from CVD each year in ESC-associated nations. The cardiovascular condition is the top reason for mortality (39%) among men in ESC member nations while 2.2 million females die because of cardiovascular condition annually in ESC associate nations around 40% of women die from CVD in the EU.

Also, according to the British Heart Foundation Released UK Factsheet in April 2023, around 7.6 million individuals are living with heart and circulatory disorders in the UK, aging and growing inhabitants and enhanced survival rates from heart and circulatory events could witness these numbers advance still additionally. About 4 million men and over 3.6 million women are living with heart and circulatory conditions in the UK, it is estimated that in the UK over half of inhabitants will encounter heart or circulatory disorders in their lifespan.

Moreover, approximately double the number of individuals living with heart and circulatory conditions in the UK compared to the number of cancer and Alzheimer's conditions cases added. Heart and circulatory disorders generate about 25% of all deaths in the UK; that's over 160,000 deaths annually, or 460 every day accounting for one death every three minutes, roughly 48,000 individuals below the age of 75 in the UK die because of heart and circulatory disorders every year.

Increasing Number of Product Approvals

The rising number of product approvals by distinct regulatory authorities is also expected to contribute to the global intracardiac echocardiography devices market growth during the forecast period. For instance, in April 2022, Franklin Mountain Medical obtained FDA authorization for its patented UltraNav Transseptal Catheter System a dual-lumen catheter that allows side-by-side, concurrent delivery of both ICE and transseptal needles or catheters via one dual-lumen device for steady access and delivery of cardiovascular catheters and guidewires to the cardiac chambers through transseptal puncture.

Similarly, in June 2021, Siemens Healthineers acquired CE Mark for the AcuNav Volume ICE (Intracardiac Echocardiography) catheter, a therapy-enabling imaging guide that delivers real-time, wide-angle visualization of cardiac anatomy in Structural Heart and Electrophysiology operations. AcuNav Volume ICE was the market's foremost Volume ICE catheter, designed based on 20 years of innovation record in ICE.

High Intracardiac Echocardiography Device Cost

The high intracardiac echocardiography devices and catheter costs are expected to be hampering the global Intracardiac Echocardiography Devices market growth during the forecast period. For instnace, the cost of a phased-array ICE catheter varies from $2,000 to $2,500, based on the volume of catheters bought. Similarly, the average list cost of cardiac 3D mapping systems varies from USD 250,000 to 800,000.

Likewise, Boston Scientific's iLAB Ultrasound Imaging System for Intracardiac Imaging costs around $131,400. Further, the average cost of a intracardiac echocardiography catheter system (USD 2000-2500) is an important barrier to the general usage of intracardiac echocardiography, slowing the global intracardiac echocardiography devices market demand in the forecast period.

Cardiologists Workforce Shortage

The cardiologists' workforce gap is expected to hamper the global intracardiac echocardiography devices market growth during the forecast period. For instance, according to the American College of Cardiology Foundation with not sufficient clinicians available to satisfy the requirements of an ever-growing patient population, the cardiology specialty domain is on the cusp of a concern. Similarly, according to the European Society of Cardiology in high-income nations, the median number of cardiologists per million inhabitants was 99.0 compared with 61.1 in middle-income nations.

Further, according to the Cardiologists Society of India (CSI), there are merely 5500 cardiologists in the country with a population of 1.3 billion, and there is only one cardiologist for the 30, 000 inhabitants in the nation. Again, according to a recent investigation from the Association of American Medical Colleges (AAMC), by 2034, the nation is predicted to be lacking anywhere from 37,000 to 124,000 medics. This contains a deficit of 17,000 to 48,000 primary care doctors and 3,000 to 13,000 experts, a category that encloses cardiologists.

Segment Analysis

The global intracardiac echocardiography devices market is segmented based on product type, imaging type, application, end-user and region.

3D Imaging Type Expected to Dominate Market

The increasing adoption of 3D intracardiac echocardiography (ICE) is expected to boost segmental growth enabling the segment to hold a majority of market share in the forecast period. For instance, in September 2022, Baptist Health's Miami Cardiac and Vascular Institute employed the VeriSight Pro, a real-time 3D intracardiac echocardiography catheter from Philips. The technology delivers exceptional 2D and 3D live imaging suggestions for a broad spectrum of cardiac operations in structural heart conditions.

Similarly, in December 2021, the Children's Hospital Colorado (Children's Colorado) was the foremost pediatric clinic in the globe to employ a 3D intracardiac echocardiography (ICE) catheter in the therapy of congenital heart conditions in the Cardiac Catheterization Lab. The live, 3D picture direction delivered by the FDA-authorized technology from Phillips permits cardiac interventionalists to sufficiently guide complicated operations, which is anticipated to result in enhanced outputs.

Geographical Penetration

Increasing Number of Cardiovascular Disorders Cases in North America

Owing to the growing cases of cardiovascular diseases in North America the region is expected to dominate the global market throughout the forecast period. For instance, according to the CDC, cardiac condition is the top reason for mortality of males, females, and individuals of most ethnical and racial levels in the United States, one individual dies every 33 seconds in the United States from cardiovascular condition.

Similarly, almost 695,000 individuals in the United States died from heart conditions in 2021 accounting for 1 in every 5 deaths. Further, the heart condition cost the United States around $239.9 billion annually from 2018 to 2019, which includes the expense of healthcare assistance, medications, and failed productivity because of death. Further, the American Heart Association has published the Heart and Stroke Statistics 2022 Update, according to that report, cardiac arrest remains a public health emergency as are over 356,000 out-of-hospital cardiac arrests (OHCA) yearly in the U.S., and almost 90% of them are deadly.

The incidence of EMS-assessed non-traumatic OHCA in individuals of any age is assessed to be 356,461, or almost 1,000 individuals every day. Survival to hospital release after EMS-treated cardiac arrest declines by approximately 10%. Additionally, in 2022, an estimated 655,000 Americans were expected to die because of heart conditions, and over 140,000 were expected to die from stroke. Accounting for one in every four deaths in the U.S. Heart condition and stroke also account for over $320 billion in healthcare expenses and failed productivity per year.

COVID-19 Impact Analysis

The COVID-19 pandemic had deep effects on cardio-pulmonary health and healthcare delivery. Direct effects enclosed information on myopericarditis jointly with highly regular information on pneumonia and pulmonary fibrosis, periodically advancing to respiratory collapse and demise. Additionally unpredictable, nevertheless, were the indirect effects of the pandemic on CV examinations and hospital admissions which have repeatedly demonstrated varying drops.

While there has been no indication of actual declines in the preponderance of CVD or the incidence of acute coronary syndromes, these reductions have extended considerations that the pandemic has directed to general under-investigation and under-treatment of many individuals. Indeed, reports from respective nations suggest substantial declines in investigative procedures for heart failure and coronary and electrophysiological conditions in 2020 corresponded with 2019. Declines in hospital admissions for a degree of CV conditions, including ST-elevation myocardial infarction, have even been registered in the same period.

By Product Type

Radial or Rotating ICE
Phased-array ICE

By Imaging Type

2D imaging
3D Imaging
4D Imaging

By Application

Electrophysiology
Left Atrial Appendage Closure
Transcatheter Aortic Valve Implantation
MitraClip Implantation and Mitral Valvuloplasty
Other

By End-User

Hospitals
Specialty Clinics
Diagnostic Centers
Other

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

In March 2022, Seimens Healthineers introduced the next-generation AcuNav Volume four-dimensional (4D) intracardiac echocardiography (ICE) catheter in the United States.
In April 2022, Franklin Mountain Medical obtained FDA authorization for its patented UltraNav Transseptal Catheter System for regulated access and delivery of cardiovascular catheters and guidewires to the heart chambers via transseptal puncture.

Competitive Landscape

The major global players in the market include Johnson & Johnson Services Inc., GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare, Abbott Laboratories, Boston Scientific Corporation, Infraredx Inc., Terumo Corporation, ESAOTE SPA, and Conavi Medical among others.

Why Purchase the Report?

To visualize the global intracardiac echocardiography devices market segmentation based on product type, imaging type, application, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of intracardiac echocardiography devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key product of all the major players.

The global intracardiac echocardiography devices market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Imaging Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Cardiovascular Disorders
  - 4.1.1.2. Increasing Number of Product Approvals
- 4.1.2. Restraints
  - 4.1.2.1. High Intracardiac Echocardiography Device Cost
  - 4.1.2.2. Cardiologists Workforce Shortage
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. Technology Trend
5.7. End-User Trend
5.8. SWOT Analysis
5.9. Russia-Ukraine War Impact
5.10. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Radial or Rotating ICE*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Phased-array ICE

8. By Imaging Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.1.2. Market Attractiveness Index, By Product Type
8.2. 2D Imaging*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. 3D Imaging
8.4. 4D Imaging

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Electrophysiology*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Left Atrial Appendage Closure
9.4. Transcatheter Aortic Valve Implantation
9.5. MitraClip Implantation and Mitral Valvuloplasty
9.6. Other

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Speciality Clinics
10.4. Diagnostic Centers
10.5. Other

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. EMS Handels Gesellschaft m.b.H.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. KONINKLIJKE PHILIPS N.V.
13.3. Medtronic
13.4. Allengers
13.5. EB NEURO S.P.A.
13.6. Shenzhen Delica Medical Equipment Co., Ltd.
13.7. Micromed Group
13.8. NIHON KOHDEN CORPORATION
13.9. Cadwell
13.10. Natus Medical Incorporated

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球心内超音波心动图设备市场 - 2023-2030

Global Intracardiac Echocardiography Devices Market - 2023-2030

概述

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按产品类型

第 8 章：按成像类型

第 9 章：按应用

第 10 章：最终用户

第 11 章：按地区

第 12 章：竞争格局

第 13 章：公司简介

第 14 章：附录